Biocon to launch drug for COVID-19 patients; priced at Rs 8,000 per vial

New Delhi, Jul 13 () Biotechnology major Biocon on Monday said it will launch biologic drug Itolizumab for the treatment of moderate to severe COVID-19 patients at a price of around 8,000 per vial.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3iYGQZ6
via IFTTT